Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: David Silverman who wrote (570)	11/22/1997 2:51:00 AM
From: Amigo Mike	Read Replies (1) \| Respond to of 1476

For those that haven't found the Antex writeup yet: westergaard.com:8080/Med/Profiles/antx9746.htm Pay close attention to the valuation model. I agree with most of it except valuation of Campylobacter since the US DOD will buy immediately when the vaccine is available and this is a worldwide product. The model does not include potential of animal applications. The valuation of $3.38 falls in line with my previous projected value of Antex. I quietly point to Antex ...... severely undervalued. Mike